Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000). (Q43956302)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000). (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

HIV transmission

0 references

anti-retroviral agent

0 references

human pregnancy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

maternal health

1 reference

based on heuristic

inferred from title

author name string

United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members

1

1 reference

Europe PubMed Central

28 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

28 November 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

28 November 2017

2

1 reference

Europe PubMed Central

28 November 2017

56-91

1 reference

Europe PubMed Central

28 November 2017

1

1 reference

Europe PubMed Central

28 November 2017

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Tran

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Viral dynamics of HIV: implications for drug development and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Antiretroviral therapy for pregnant women

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Incidence of premature birth and neonatal respiratory disease in infants of HIV-positive mothers. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Metabolism of 3'-azido-3'-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Zidovudine phosphorylation after short-term and long-term therapy with zidovudine in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

HIV transmission through breastfeeding: a study in Malawi

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Pregnancy outcomes by mode of delivery among term breech births: Swedish experience 1987-1993.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal and infant complications in high and normal weight infants by method of delivery

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal and neonatal outcome of 846 term singleton breech deliveries: seven-year experience at a single center

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal consequences of caesarean section. A retrospective study of intra-operative and postoperative maternal complications of caesarean section during a 10-year period

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Comparison of a trial of labor with an elective second cesarean section

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Post-cesarean section morbidity in HIV-positive women

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal complications after caesarean section in HIV infected women

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Surfactant-deficient respiratory distress after elective delivery at 'term'.

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

T lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Heterosexual behavior during pregnancy and perinatal transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Evaluation and Medical Treatment of the HIV-Exposed Infant

1 reference

https://api.crossref.org/works/10.1310%2F3ENW-TR0F-UQ0B-GWKD

21 January 2018

Identifiers

10.1310/3ENW-TR0F-UQ0B-GWKD

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43956302&oldid=2104641671"